does glp 1 cause blood clots GLP-1 Therapies May Benefit MPN And MDS Patients Deep Vein Thrombosis (DVT) &

Using propensity matching, the researchers compared 2,894 patients taking a GLP-1 receptor agonist at baseline with 2,894 patients not taking one at baseline

Real Value

Unstructured lifestyle changes, meaning diet shifts or exercise increases that patients made on their own outside clinical settings, were not visible in the data either

52 Economic and Political Headwinds: The IRA and TrumpRx The traditional model of maintaining high-monopoly prices for GLP-1 therapies is facing new challenges from U.S

Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men

Oct 12 : The FDA greenlit Pfizers Braftovi (encorafenib)/Mektovi (binimetinib) combination for the treatment of adult patients with non-small cell lung cancer (NSCLC) with a BRAF V600E mutation as confirmed by an FDA-approved test